These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23965425)

  • 1. Quality-control: from record keeping to key performance indicators: manging quality in compounding pharmacies.
    Braga GK; Fonseca MJ
    Int J Pharm Compd; 2010; 14(2):136-9. PubMed ID: 23965425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Simplified Method for Compounding Lidocaine Topical Gel: A Demonstration of Quality Assurance to Prevent Errors in 503A Pharmacies.
    Hall E; Levesque D; Rashid M; Mullins R; Hossain MF
    Int J Pharm Compd; 2021; 25(3):197-204. PubMed ID: 34125709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical Compounding in Portuguese Community Pharmacies: CHARACTERIZATION AND FUTURE PERSPECTIVES.
    Palmeira-de-Oliveira R; Macedo M; Machado RM; Pacheco AF; Palmeira-de-Oliveira A; Martinez-de-Oliveira J; Duarte P
    Int J Pharm Compd; 2016; 20(2):114-22. PubMed ID: 27323423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brazilian National System for the Monitoring and Improvement of Compounding Practices: program outcomes.
    de Souza HG; Favaro A; Andrade AL; Gomes LY; Garcez Mdo C
    Int J Pharm Compd; 2012; 16(2):98-102. PubMed ID: 23050320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance Improvement in 503A Compounding Pharmacies: A PLAN FOR ASSESSMENT, IMPLEMENTATION, AND SUSTAINED SUCCESS.
    Pritchett J; Mixon W; O'Connell K
    Int J Pharm Compd; 2016; 20(1):29-36. PubMed ID: 27125054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specialized compounding in community pharmacies: organizational perspective.
    Giam JA; McLachlan AJ; Krass I
    J Am Pharm Assoc (2003); 2010; 50(3):354-61. PubMed ID: 20452908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compounding pharmacies: who is in charge?
    Pergolizzi JV; Labhsetwar S; LeQuang JA
    Pain Pract; 2013 Mar; 13(3):253-7. PubMed ID: 23350709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality-control analytical methods: continuous quality improvement.
    Venti EM
    Int J Pharm Compd; 2006; 10(6):442-4. PubMed ID: 23974418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obtaining accreditation by the pharmacy compounding accreditation board, part 3: developing a program of qualtity assurance and continuous qualtiy improvement.
    Cabaleiro J
    Int J Pharm Compd; 2008; 12(3):234-6. PubMed ID: 23969712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality Control, Quality Assurance, and Quality Improvement-What is the Difference and Why Should Compounding Pharmacies Care?
    Cabaleiro J
    Int J Pharm Compd; 2009; 13(4):318-20. PubMed ID: 23966522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Records and record-keeping for the hospital compounding pharmacist.
    McElhiney LF
    Int J Pharm Compd; 2007; 11(2):136-41. PubMed ID: 23974620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe.
    Minghetti P; Pantano D; Gennari CG; Casiraghi A
    Health Policy; 2014 Sep; 117(3):328-33. PubMed ID: 25110297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the review of standard operating procedures: a novel electronic system for compounding pharmacies.
    Brensel R; Brensel S; Ng A
    Int J Pharm Compd; 2013; 17(6):465-75. PubMed ID: 24579296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a standardized Intranet database of formulation records for nonsterile compounding, Part 2.
    Haile M; Anderson K; Evans A; Crawford A
    Int J Pharm Compd; 2012; 16(2):104-9. PubMed ID: 23050321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Setting up a national system of compounding pharmacies: preventing error, assuring quality, building trust.
    de Souza HG; Favaro A; Andrade AL; Gomes LY; Aguiar Sde S; Garcez Mdo C
    Int J Pharm Compd; 2009; 13(6):532-6. PubMed ID: 23965327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in compounding of oral liquids for pediatric patients: a patient safety concern.
    Rood JM; Engels MJ; Ciarkowski SL; Wagenknecht LD; Dickinson CJ; Stevenson JG
    J Am Pharm Assoc (2003); 2014; 54(4):383-9. PubMed ID: 25063260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing specialized compounding in community pharmacies.
    Giam JA; McLachlan AJ; Krass I
    Res Social Adm Pharm; 2012; 8(3):240-52. PubMed ID: 21824824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges of standardized continuous quality improvement programs in community pharmacies: the case of SafetyNET-Rx.
    Boyle TA; MacKinnon NJ; Mahaffey T; Duggan K; Dow N
    Res Social Adm Pharm; 2012; 8(6):499-508. PubMed ID: 22421196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality planning, part 1: a holistic and practical approach.
    Odegard RD
    Int J Pharm Compd; 2013; 17(5):393-9. PubMed ID: 24459786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.